RegenErect Recalled After FDA Analysis Reveals Undisclosed Ingredient

Criticism, regarding fraudulent practices within the dietary supplement industry, has once again been validated by the actions of negligent companies. Regeneca, Inc. (formerly Ethos Environmental, Inc.) notified the public of a nationwide recall of all lots of single-capsule packet RegenErect. A U.S. Food and Drug Administration (FDA) lab analysis confirmed the presence of undisclosed ingredients. The FDA analysis discovered traces of tadalafil, a derivative of sulfoaildenafil, an FDA-approved drug already used as treatment for male erectile dysfunction (ED). The inclusion of tadalafil, without disclosure, may pose as a significant threat to certain individuals.

RegenErect was developed and marketed as a dietary supplement capable of assisting in the treatment of erectile dysfunction. Furthermore, RegenErect boasted the ability to provide men with a long lasting erection, making sexual intercourse more pleasurable.

However, RegenErect was discovered to have been the byproduct of fraudulent practices committed by Regeneca, Incorporated. According to an FDA lab analysis, RegenErect contains undisclosed ingredients. Officials at the FDA discovered traces of tadalafil within the pills that was not disclosed on ingredient labels. Tadalafil is an analogue of the FDA approved sulfoaildenafil, an ingredient indicated to treat male erectile dysfunction. However, the inclusion of tadalafil may pose as a serious risk to certain individuals who are unaware they are taking it.

The undisclosed ingredient poses as a threat to consumers because it may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Subsequently, ED is a common problem in men with these conditions, and they may seek products to enhance sexual performance.

Due to the significantly lowered blood pressure that may occur when tadalafil is introduced to nitrates, Regeneca, Inc. notified the public of a nationwide recall of all lots of single-capsule packet RegenErect. RegenErect is a blue capsule sold individually in foil packets with a UPC code of 816860010055. RegenErect was distributed via sales made over the internet to consumers in the United States of America and Puerto Rico, and given as samples at public events.

Do I Have a RegenErect Lawsuit?

The trial lawyers at The Senators (Ret.) Firm, LLP have decades of experience navigating through complex legislative and regulatory issues and litigating high stakes cases all over the nation. Our law firm focuses on the representation of plaintiffs in RegenErect lawsuits. We are currently accepting new cases in all 50 states.

If you or a loved one has been injured by RegenErect, you may be entitled to financial compensation. For a free case review, please click the link below or call toll free 24 hrs/day 1-(949) 557-5800.